Sword Health's AI-powered platform offers remote monitoring, virtual PT sessions, behavioral health support, and personalized care plans for treating chronic pain.
Rune Labs leverages real-world data and digital biomarkers to revolutionize the treatment of neurodegenerative diseases like Parkinson's, enabling personalized and data-driven care.
Anterior is transforming healthcare with AI that understands clinical jargon, delivering value by automating administrative tasks like prior authorization that cost over $1 trillion annually.
Leveraging an AI-powered immune profiling platform, IMU Biosciences creates unprecedented insights into health and disease by measuring and analyzing the immune system at an unparalleled scale and resolution.
Proprio's proprietary platform provides surgeons with insightful, responsive information in the operating room, aiming to significantly improve patient outcomes and surgeon wellbeing by enhancing surgical performance and precision.
Relation leverages single-cell multi-omics, functional assays, and machine learning to better characterize diseases and develop transformational medicines.
Automata's LINQ platform integrates lab instruments, robotics, and cloud software to streamline scientific workflows and accelerate drug discovery research.
Perspectum enables non-invasive "virtual biopsies" that provide safer, more accessible disease monitoring for conditions like liver disease, diabetes, and cancer.
Happiest Baby's SNOO Smart Sleeper is an FDA-approved cradle that tracks baby's sleep, sends alerts, and automatically soothes with womb-like motions.
PhaseV is pioneering the use of reinforcement learning, causal ML, and adaptive trial design to optimize resource utilization and time efficiency in drug development.
MDI Health has developed an innovative AI solution used by payers and value-based providers to optimize medication management, identify high-risk patients, and reduce overall healthcare expenditure.
Ikerian is pioneering the use of non-invasive retinal imaging and AI to identify biomarkers that can predict disease progression and treatment response.
Ibex AI's Galen™ platform demonstrated outstanding outcomes in clinical studies and helps pathologists and providers reduce diagnostic errors, implement real-time quality control, reduce diagnosis time and boost productivity.
Zoundream's solution uses AI to analyze infant cries and sounds in real-time, pinpointing reasons such as hunger or tiredness with remarkable accuracy, and detecting early signs of conditions like autism.
Featuring Mendel, Akrivia Health, Epistemix, Ovation, and Evidation Health, this episode explores how innovative companies are leveraging real-world data and AI to drive precision medicine, uncover new treatments, and improve population health outcomes.
Explore how CareJourney, Aidoc, Forward, CLEW, and Thyme Care leverage cutting-edge technologies to optimize clinician and patient experiences, driving better outcomes and transforming healthcare delivery.
Featuring Deep6 AI, Lokavant, and Science 37, this episode explores how these companies are leveraging AI, data analytics, and decentralized models to revolutionize clinical trial recruitment, operations, and patient accessibility.
Explore how Us2.AI, Truvian Health, and Sparta Science leverage AI, cloud, and novel biological insights to revolutionize diagnostics and biomarker discovery, enabling accessible and precise care pathways.
Dive into the groundbreaking approaches of companies like VivoDyne, Seer, Ordaos, Insilico Medicine, and Alchemab, who are pushing boundaries in drug R&D through microfluidic bioengineering, proteome mapping, AI-driven drug design, and resilient antibody discovery.
Mendel enables life sciences to index patient journeys at scale and learn from them at the speed of real-time dialogues. The journey started in 2017 from a two-person office in Silicon Valley with commitment to building novel technology and not to be another “Boy Who Cried Wolf” AI company. To do that, we have invested 4 years and millions of dollars in R&D before launching our first model in 2020. Today, Mendel is the most-funded clinical NLP startup with a team of 100+ members, blue chip investors, and some of the world’s leading life sciences companies as customers.